| Dec 10, 2024 |
Dec 12, 2024 |
Scholar Rock Holding Corp
|
10% Owner |
Sell |
15.0
|
-1,600,000
|
-14.75%
|
✗
|
$66.6M |
| Nov 25, 2024 |
Nov 27, 2024 |
Scholar Rock Holding Corp
|
10% Owner |
Sell |
15.0
|
-409,433
|
-3.64%
|
✗
|
$15.8M |
| Aug 7, 2024 |
Aug 9, 2024 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
22.5
|
-322,361
|
-4.85%
|
✗
|
$61.2K |
| Aug 5, 2024 |
Aug 7, 2024 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
26.3
|
-220,255
|
-3.21%
|
✗
|
$41.2K |
| Aug 1, 2024 |
Aug 5, 2024 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
22.5
|
-349,764
|
-4.85%
|
✗
|
$71.1K |
| Jul 26, 2024 |
Jul 30, 2024 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Sell |
20.0
|
-1,379,119
|
-16.06%
|
✗
|
$315.3K |
| Oct 12, 2023 |
Oct 16, 2023 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
100.0
|
+2,199,931
|
24.28%
|
✗
|
$15.1M |
| Jun 5, 2023 |
Jun 5, 2023 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+27,775,050
|
54.61%
|
✗
|
$72.2M |
| Apr 28, 2023 |
May 2, 2023 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
65.0
|
+31,557
|
0.35%
|
✗
|
$202.8K |
| Feb 24, 2023 |
Feb 28, 2023 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
82.5
|
+100,000
|
1.18%
|
✗
|
$170K |
| Feb 21, 2023 |
Feb 23, 2023 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
90.0
|
+400,000
|
4.94%
|
✗
|
$712.3K |
| Feb 15, 2023 |
Feb 17, 2023 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
100.0
|
+1,515,266
|
23.05%
|
✗
|
$3M |
| Feb 9, 2023 |
Feb 13, 2023 |
CRESCENT BIOPHARMA, INC.
|
10% Owner |
Buy |
56.3
|
+11,451
|
0.17%
|
✗
|
$37.1K |
| Jan 9, 2023 |
Jan 11, 2023 |
Scholar Rock Holding Corp
|
10% Owner |
Sell |
51.3
|
-1,094
|
-0.01%
|
✗
|
$10.4K |
| Jan 5, 2023 |
Jan 9, 2023 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
75.0
|
+48,774
|
0.54%
|
✗
|
$455.1K |
| Oct 25, 2022 |
Oct 27, 2022 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
87.5
|
+130,265
|
1.47%
|
✗
|
$1M |
| Oct 3, 2022 |
Oct 7, 2022 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
85.0
|
+99,971
|
1.14%
|
✗
|
$759.5K |
| Aug 5, 2022 |
Aug 9, 2022 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
96.3
|
+2,426,070
|
5.01%
|
✗
|
$6.1M |
| Aug 1, 2022 |
Aug 1, 2022 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+16,173,800
|
50.14%
|
✗
|
$40.4M |
| Feb 1, 2021 |
Feb 3, 2021 |
Seer, Inc.
|
10% Owner |
Sell |
15.0
|
-252,545
|
-4.32%
|
✗
|
$16.2M |
| Dec 16, 2020 |
Dec 17, 2020 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+10,937,500
|
51.30%
|
✗
|
$35M |
| Dec 8, 2020 |
Dec 10, 2020 |
Seer, Inc.
|
10% Owner |
Buy |
100.0
|
+790,000
|
15.64%
|
✗
|
$15M |
| Jun 16, 2020 |
Jun 18, 2020 |
Generation Bio Co.
|
10% Owner |
Buy |
100.0
|
+800,000
|
39.72%
|
✗
|
$15.2M |
| Jun 27, 2018 |
Jun 29, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
95.0
|
+182,838
|
5.49%
|
✗
|
$2.3M |
| Jun 22, 2018 |
Jun 26, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
95.0
|
+253,725
|
8.24%
|
✗
|
$3.3M |
| Jun 19, 2018 |
Jun 21, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
85.0
|
+72,973
|
2.43%
|
✗
|
$970K |
| Jun 14, 2018 |
Jun 18, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
85.0
|
+45,784
|
1.55%
|
✗
|
$594.4K |
| Jun 8, 2018 |
Jun 12, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
95.0
|
+235,396
|
8.64%
|
✗
|
$3M |
| Jun 5, 2018 |
Jun 7, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+325,639
|
13.57%
|
✗
|
$4.1M |
| May 31, 2018 |
Jun 4, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+416,481
|
21.00%
|
✗
|
$5M |
| May 29, 2018 |
May 31, 2018 |
Scholar Rock Holding Corp
|
10% Owner |
Buy |
100.0
|
+450,000
|
100.00%
|
✗
|
$6.3M |
| May 25, 2018 |
May 30, 2018 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+433,378
|
27.96%
|
✗
|
$4.3M |
| Nov 15, 2017 |
Nov 17, 2017 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+180,727
|
13.20%
|
✗
|
$1.8M |
| Nov 10, 2017 |
Nov 14, 2017 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+575,946
|
72.60%
|
✗
|
$5.6M |
| Nov 26, 2014 |
Nov 26, 2014 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
100.0
|
+149,253,731
|
100.00%
|
✗
|
$150M |
| Oct 23, 2012 |
Oct 25, 2012 |
LEXICON PHARMACEUTICALS, INC.
|
Director |
Buy |
88.8
|
+3,000,000
|
1.07%
|
✗
|
$6.8M |